AR047765A1 - Metodos y composiciones que comprenden ilex - Google Patents
Metodos y composiciones que comprenden ilexInfo
- Publication number
- AR047765A1 AR047765A1 ARP040103864A ARP040103864A AR047765A1 AR 047765 A1 AR047765 A1 AR 047765A1 AR P040103864 A ARP040103864 A AR P040103864A AR P040103864 A ARP040103864 A AR P040103864A AR 047765 A1 AR047765 A1 AR 047765A1
- Authority
- AR
- Argentina
- Prior art keywords
- compositions
- methods
- caffeine
- ilex
- preparing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Métodos para preparar composiciones derivadas de especies Ilex, particularmente Ilex paraguareniensis, que poseen concentraciones de tanino y cafeína inferiores, composiciones preparadas por dichos métodos, formulaciones de consumo oral, y métodos de uso de tales composiciones. En particular, comprende métodos para preparar composiciones de yerba mate que poseen una característica predeterminada, tal como cantidad disminuida de cafeína, cantidades elevadas de cafeoilos, y/o cantidades inferiores de compuestos de tanino comparadas con las de los materiales de planta de yerba mate autoctona. Además comprende métodos de pasos de procesamiento adicional para producir composiciones que poseen un índice alcaloide predeterminado o perfiles para satisfacer consideraciones particulares para productos finales. Las composiciones e la presente pueden ser procesadas para usos específicos tales como tabletas u otros vehículos de consumo oral. Estas composiciones pueden ser utilizadas en métodos para el tratamiento de condiciones fisiologicas y medicinales.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51418703P | 2003-10-24 | 2003-10-24 | |
US10/970,017 US7294353B2 (en) | 2003-10-24 | 2004-10-21 | Methods and compositions comprising ilex |
Publications (1)
Publication Number | Publication Date |
---|---|
AR047765A1 true AR047765A1 (es) | 2006-02-22 |
Family
ID=34526963
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040103864A AR047765A1 (es) | 2003-10-24 | 2004-10-22 | Metodos y composiciones que comprenden ilex |
Country Status (5)
Country | Link |
---|---|
US (1) | US7294353B2 (es) |
EP (1) | EP1691821A1 (es) |
AR (1) | AR047765A1 (es) |
CA (1) | CA2541629A1 (es) |
WO (2) | WO2005039612A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1917892A (zh) * | 2003-10-24 | 2007-02-21 | 草本制药科学有限责任公司 | 包含冬青的方法和组合物 |
BRPI0709379A2 (pt) * | 2006-03-17 | 2011-07-12 | Herbalscience Singapore Pte Ltd | extratos e métodos que compreendem espécies de cúrcuma |
BRPI0709566A2 (pt) * | 2006-03-17 | 2011-07-19 | Herbalscience Singapore Pte Ltd | extrações e métodos que compreendem espécies de sabugueiro |
WO2007109802A2 (en) * | 2006-03-23 | 2007-09-27 | Herbalscience Singapore Pte. Ltd. | Extracts and methods comprising green tea species |
JP2009531330A (ja) * | 2006-03-23 | 2009-09-03 | ハーバルサイエンス シンガポール ピーティーイー. リミテッド | 霊芝種を含む抽出物および方法 |
US8481101B2 (en) * | 2006-05-11 | 2013-07-09 | Sol Mate Ag | Mate beverage |
US8360072B2 (en) | 2009-10-09 | 2013-01-29 | Philip Morris Usa Inc. | Combination treatment of tobacco extract using antioxidants and antioxidant scavengers |
US8241680B2 (en) | 2010-06-30 | 2012-08-14 | Rock Creek Pharmaceuticals, Inc. | Nutraceutical product containing anatabine and yerba maté |
CN104169269A (zh) | 2011-08-29 | 2014-11-26 | Rcp发展股份有限公司 | 用于抗炎支持的产品 |
JP7346394B2 (ja) | 2017-10-06 | 2023-09-19 | カーギル インコーポレイテッド | 感覚変更化合物 |
JP7391993B2 (ja) | 2019-04-06 | 2023-12-05 | カーギル インコーポレイテッド | 植物抽出組成物を作製するための方法 |
EP3952667A1 (en) | 2019-04-06 | 2022-02-16 | Cargill, Incorporated | Sensory modifiers |
Family Cites Families (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2115411A (en) * | 1935-06-26 | 1938-04-26 | Clarence H Venner Jr | Preparation of yerba mate |
GB943121A (en) | 1961-05-24 | 1963-11-27 | Thomae Gmbh Dr K | Medicines containing lactones from piper methysticum |
US4154823A (en) * | 1976-06-10 | 1979-05-15 | Schutt Steven R | Skin treatment compositions and methods of using same |
US4248861A (en) * | 1979-02-21 | 1981-02-03 | Schutt Steven R | Skin treatment methods |
US5178735A (en) * | 1987-09-07 | 1993-01-12 | Chlorine Engineers | Process for the supercritical extraction and separation of solid samples |
WO1991001367A1 (en) * | 1989-07-20 | 1991-02-07 | Bioeng, Inc. | Supercritical fluid disruption of and extraction from microbial cells |
US5296224A (en) * | 1990-09-12 | 1994-03-22 | Dr. Wilmar Schwabe Gmbh & Co. | Kava-kava extract, process for the production thereof and use thereof |
US5466455A (en) * | 1990-10-18 | 1995-11-14 | Huffstutler, Jr.; Miles C. | Polyphase fluid-extraction process, resulting products and methods of use |
US5174542A (en) * | 1991-02-08 | 1992-12-29 | Deleeuw Jr William D | Secure mount for trolling motor |
US5234947A (en) * | 1991-11-07 | 1993-08-10 | New York University | Potassium channel activating compounds and methods of use thereof |
DE4201179A1 (de) * | 1992-01-17 | 1993-07-22 | Alfatec Pharma Gmbh | Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung |
US5578307A (en) * | 1992-01-17 | 1996-11-26 | Alfatec-Pharma Gmbh | Shaped articles containing plant extract(s), in particular pellets, and their pharmaceutical or cosmetic use |
JP4260877B2 (ja) * | 1992-03-02 | 2009-04-30 | バイオエング・インコーポレーテッド | ウイルスの不活性化方法 |
US5639441A (en) * | 1992-03-06 | 1997-06-17 | Board Of Regents Of University Of Colorado | Methods for fine particle formation |
DE4322330A1 (de) * | 1992-08-31 | 1994-03-03 | Behringwerke Ag | Verwendung des IL-4-Rezeptors zur Therapie, Prophylaxe und Diagnose von allergischen, viralen, parasitären und bakteriellen Erkrankungen sowie von Pilzinfektionen |
US5273754A (en) * | 1992-03-27 | 1993-12-28 | Mann Morris A | Appetite suppressant composition and method relating thereto |
GB2276392B (en) * | 1993-02-22 | 1997-03-26 | D G P | Improved production of natural flavours and fragrances |
US5440055A (en) * | 1993-03-12 | 1995-08-08 | Aphios Corporation | Method and apparatus for extracting taxol from source materials |
US5854064A (en) * | 1996-07-31 | 1998-12-29 | Aphios Corporation | Methods for fractionation of biologically-derived materials |
US5554382A (en) * | 1993-05-28 | 1996-09-10 | Aphios Corporation | Methods and apparatus for making liposomes |
US5776486A (en) * | 1993-05-28 | 1998-07-07 | Aphios Corporation | Methods and apparatus for making liposomes containing hydrophobic drugs |
FR2717381B1 (fr) * | 1994-03-15 | 1996-04-19 | Oreal | Compositions à base d'alpha-pyrones pour induire et stimuler la croissance des cheveux et/ou freiner leur chute et utilisation. |
US5567439A (en) * | 1994-06-14 | 1996-10-22 | Fuisz Technologies Ltd. | Delivery of controlled-release systems(s) |
PT730830E (pt) * | 1995-03-06 | 2002-07-31 | Flachsmann Ag Emil | Processo para a eliminacao de impurezas lipofilas e/ou residuos indesejaveis contidos em bebidas ou preparados de plantas |
US5698199A (en) * | 1995-03-10 | 1997-12-16 | Kao Corporation | Lipolysis acceleration method |
FR2737720B1 (fr) * | 1995-08-10 | 1997-10-24 | Mediterranneenne D Aerosols Sn | Composition incapacitante, et dispositif pour sa mise en oeuvre |
DE19646977A1 (de) * | 1995-09-29 | 1998-01-15 | Schwabe Willmar Gmbh & Co | Stabiler Extrakt aus Hypericum perforatum L., Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen |
DE19606545A1 (de) * | 1996-02-22 | 1997-08-28 | Wella Ag | Kosmetisches Mittel mit einem Gehalt an Ilexharz, Verfahren zur Gewinnung von Ilexharz und durch dieses Verfahren erhältliches Ilexharz |
US5891465A (en) * | 1996-05-14 | 1999-04-06 | Biozone Laboratories, Inc. | Delivery of biologically active material in a liposomal formulation for administration into the mouth |
CN1098120C (zh) * | 1996-05-23 | 2003-01-08 | 大正制药株式会社 | 微滴乳状液 |
US5776935A (en) * | 1996-07-25 | 1998-07-07 | Merz & Co. Gmbh & Co. | Pyrido-phtalazin diones and their use against neurological disorders associated with excitotoxicity and malfunctioning of glutamatergic neurotransmission |
CH690817A5 (de) * | 1996-09-03 | 2001-01-31 | Flachsmann Ag Emil | Verfahren zur Herstellung eines stabilen, homogenen, von Folgeprodukten freien oder nahezu freien Extraktes. |
US6080410A (en) * | 1997-03-17 | 2000-06-27 | Natrol, Inc. | Method for reducing daily stress and anxiety in adults |
US5770207A (en) * | 1997-03-17 | 1998-06-23 | Natrol, Incorporated | Dietary supplements containing kava root extract, passion flower, chamomile flowers, hops, and schizandra fruit |
DE19714450A1 (de) * | 1997-04-08 | 1998-10-15 | Schwabe Willmar Gmbh & Co | Stabiler Extrakt aus Hypericum perforatum L., Verfahren zu seiner Herstellung und pharmazeutische Zubereitung |
US5906825A (en) * | 1997-10-20 | 1999-05-25 | Magellan Companies, Inc. | Polymers containing antimicrobial agents and methods for making and using same |
DE19750623A1 (de) * | 1997-11-14 | 1999-05-20 | Schwabe Willmar Gmbh & Co | Pyranone, Verfahren zu ihrer Herstellung und Verwendung |
WO1999061038A1 (en) | 1998-05-29 | 1999-12-02 | Adams Food Ltd. | Composition having therapeutic and/or nutritionally active substituent |
US6045825A (en) * | 1998-06-17 | 2000-04-04 | M. E. Cody Products, Inc. | Plantago major and Piper methysticum compound for use in treating a tobacco or nicotine habit |
US6159473A (en) * | 1998-06-24 | 2000-12-12 | Botanical Laboratories, Inc. | Sore throat spray |
US6068846A (en) * | 1998-08-05 | 2000-05-30 | Melaleuca, Incorporated | Methods and materials for treating depression and mood disorder |
US6143300A (en) * | 1998-08-11 | 2000-11-07 | Robin Ann Stevenot | Fem-Ease, a supplement for the symptoms of cystitis, urinary tract infections and premenstrual syndrome |
EP0987026A1 (de) | 1998-08-21 | 2000-03-22 | Max Zeller Söhne AG | Verfahren zur Herstellung eines Kawa-Kawa-Extraktes |
US6025363A (en) * | 1998-11-17 | 2000-02-15 | Giles, Jr.; James A. | Composition for suppressing appetite |
US5977120A (en) * | 1998-11-17 | 1999-11-02 | Giles, Jr.; James A. | Composition for achieving an alert, yet calm state |
US5976550A (en) * | 1998-11-20 | 1999-11-02 | Engel; Peter H. | Dietary food supplement |
US6238722B1 (en) * | 1999-03-10 | 2001-05-29 | Timothy Meadows | Method for producing finely ground kava root |
US6322806B1 (en) * | 1999-04-06 | 2001-11-27 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations including tableted center |
CA2414094A1 (en) | 1999-05-27 | 2000-12-07 | Armadillo Pharmaceuticals, Inc. | Pharmaceutical preparations of bioactive substances extracted from natural sources |
US6174542B1 (en) | 1999-07-01 | 2001-01-16 | Pms Mood Food, Inc. | Dietary supplements and food products for treating symptoms of PMS |
US6117431A (en) * | 1999-12-03 | 2000-09-12 | Pharmline Inc. | Method for obtaining an extract from ginkgo biloba leaves |
US6312736B1 (en) * | 1999-12-09 | 2001-11-06 | Biotech Corporation | Herbal composition to relieve pain |
US6238696B1 (en) * | 2000-01-07 | 2001-05-29 | Gaia Herbs, Inc. | Process for providing herbal medicants in cellulose derivative capsules |
US6277396B1 (en) * | 2000-05-11 | 2001-08-21 | Maximum Human Performance, Inc. | Dietary supplement containing a thermogenic substance and an adrenal support substance |
US7045159B1 (en) * | 2000-09-19 | 2006-05-16 | Rutgers, The State University Of New Jersey | Antiviral substances from plant cuticular and epiciticular material |
US20020187169A1 (en) * | 2001-05-11 | 2002-12-12 | Shoujun Chen | Kavalactone compositions |
CN1917892A (zh) * | 2003-10-24 | 2007-02-21 | 草本制药科学有限责任公司 | 包含冬青的方法和组合物 |
-
2004
- 2004-10-21 US US10/970,017 patent/US7294353B2/en not_active Expired - Fee Related
- 2004-10-22 WO PCT/US2004/035170 patent/WO2005039612A1/en active Application Filing
- 2004-10-22 AR ARP040103864A patent/AR047765A1/es unknown
- 2004-10-25 WO PCT/US2004/035098 patent/WO2005041997A1/en active Application Filing
- 2004-10-25 EP EP04796147A patent/EP1691821A1/en not_active Withdrawn
- 2004-10-25 CA CA002541629A patent/CA2541629A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US7294353B2 (en) | 2007-11-13 |
US20050089591A1 (en) | 2005-04-28 |
WO2005039612A1 (en) | 2005-05-06 |
CA2541629A1 (en) | 2005-05-12 |
WO2005041997A1 (en) | 2005-05-12 |
EP1691821A1 (en) | 2006-08-23 |
WO2005041997A8 (en) | 2006-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR047765A1 (es) | Metodos y composiciones que comprenden ilex | |
AR044953A1 (es) | Bacterias de acido lactico que producen equol, una composicion que comprende dichas bacterias de acido lactico y un metodo para producir equol utilizando dichas bacterias de acido lactico | |
AR048181A1 (es) | Composicion de ingredientes funcionales | |
CO6561830A2 (es) | Vacuna de péptido ch3 de ige | |
AR053680A1 (es) | Composicion | |
DOP2006000084A (es) | Compuestos sulfoximino-macrociclicos y sus sales, composiciones farmaceuticas que comprenden dichos compuestos, metodos de preparacion y usos de los mismos | |
AR047928A1 (es) | Derivados de tetrahidropiridoindol | |
CL2009000241A1 (es) | Compuestos derivados de 5-(2-morfolin-4-il-7h-pirrolo[2,3-d]pirimidin-4-il)pirimidin-2-ilamina; proceso de preparacion; composicion farmaceutica; y uso de los compuestos para tratar o prevenir una enfermedad proliferativa tal como el cancer. | |
CU20120084A7 (es) | Compuestos derivados de triazolopiridina sustituidos como inhibidores de la quinasa mps-1 y compuestos intermediarios para su preparación | |
UY29341A1 (es) | Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricación | |
AR056081A1 (es) | Composicion que es posible de dispersar en agua y metodo para prepararla | |
BRPI0508579A (pt) | composto, composição farmacêutica, e, uso de um composto | |
CL2011000144A1 (es) | Compuestos derivados de benzo (1,4) dioxin-2-ilmetil-sulfamida; composiciones farmaceuticas que los contienen; proceso para prepararlos y uso en el tratamiento de la ansiedad, epilepsia, dolor, abuso de sustancias, trastornos relacionados, entre otros. | |
PA8583001A1 (es) | Derivados de 4-pirrolidino-fenil-bencil eter como inhibidores de mao-b | |
CY1108521T1 (el) | Παρασκευη αλδεσλευκινης για φαρμακευτικη χρηση | |
TW200501965A (en) | Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle | |
WO2008106979A3 (en) | Pharmaceutical compositions comprising flavonoids and xylitol | |
BRPI0509667B8 (pt) | composto, processo para a preparação de um composto de fórmula (i), medicamento e uso de um composto | |
DK1638582T3 (da) | Anvendelse af hyaluronsyre til fremstilling af kompositioner til behandling af tilbagevendende after | |
CO2019003761A2 (es) | Derivados sustituidos de 6-(1h-pirazol-1-il)pirimidin-4-amina y usos de los mismos | |
WO2007107328A3 (en) | Subcutaneous implants containing a degradation-resistant polylactide polymer and a lh-rh analogue | |
WO2010017626A8 (en) | Compositions comprising terpene compounds for treating negative sensory phenomena | |
CL2008001559A1 (es) | Compuestos heterociclos que contienen al menos un atomo de nitrogeno, moduladores de gamma secretasa; composiciones farmaceuticas que los comprenden; uso de los compuestos en la preparacion de medicamentos para tratar trastornos del sistema nervioso central, tal como alzheimer; y kit que incluye a la composicion farmaceutica. | |
UY29371A1 (es) | Pirroles sustituídos, composiciones que los contienen, proceso de fabricación y utilización | |
BRPI0712478B8 (pt) | uso de material de planta ou extrato do material de planta |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |